targeted sequencing

Burning Rock Q4 Revenues Rise 50 Percent

Guardant360 CDx Receives CE Mark for Tumor Mutational Profiling and Tagrisso CDx Use

Illumina, PierianDx Expand Partnership on Cancer Panel Test Reporting

Tempus Gets CE Mark for xT Tumor Sequencing Assay

SVB Leerink Initiates Coverage of Natera With Outperform Rating

FDA Approves Thermo Fisher Scientific CDx for Genentech's Gavreto in NSCLC Patients With RET Fusions

Natera, MGH to Collaborate in Early-Stage Breast Cancer Clinical Trial of Targeted Therapy

Helix Gets FDA Emergency Use Authorization for NGS-Based COVID-19 Test

TMB Harmonization Effort Yields Calibration Method to Correct Inter-Assay Variation

Devyser Gains CE Mark for NGS Hereditary Breast and Ovarian Cancer Test

Avida Biomed Developing Hybridization-Based Methylation Sequencing Panels for Cancer Dx

Adaptive Biotechnologies Q1 Revenues Grow 65 Percent

Lexogen Nabs Austrian Funding for RNA-Seq Coronavirus Test

FDA Clears Cancer Genomic Profiling Kit From Personal Genome Diagnostics

Natera Expands IP Lawsuit Against ArcherDx With Three New Patents

Fulgent Genetics, MedScan Laboratory Partner to Offer NGS Coronavirus Test

Fulgent Genetics Q4 Revenues Grow 48 Percent